EyePoint Pharmaceuticals, Inc. ikhonkco yemakethe

EyePoint Pharmaceuticals, Inc. i-capital capital

Namhlanje i-market capital EyePoint Pharmaceuticals, Inc. ingu-260 694 432 US dollar.

+38 075 104 $ (+17.10%)

utshintsho lwentengo ukususela ngezolo

EyePoint Pharmaceuticals, Inc. i-capital capital kwi-dollar namhlanje. Ulwazi lwe EyePoint Pharmaceuticals, Inc. capitalisation ithathwe kwimithombo evulekileyo. EyePoint Pharmaceuticals, Inc. capitalisation ibalwa ngokusekelwe kuthengiso lwesitokhwe. EyePoint Pharmaceuticals, Inc. i-capitalization ikhula nge- $ 38 075 104.

EyePoint Pharmaceuticals, Inc. ivolumu yezorhwebo

Namhlanje inani lemali yokuthengisa EyePoint Pharmaceuticals, Inc. lingama-704 705 US dollar.

+142 310 $ (+25.30%)

utshintsho lwendleko yorhwebo ukususela ngezolo

EyePoint Pharmaceuticals, Inc. iivolumu zorhwebo namhlanje zifikelele kwi $ 704 705. EyePoint Pharmaceuticals, Inc. itshathi yevolumu yorhwebo inikezelwa kwiwebhusayithi yonke imihla. EyePoint Pharmaceuticals, Inc. kubanjwe kuthengiso oluninzi lwesitoko ngexesha langempela, sibonisa umthamo wokuthengisa wemihla ngemihla EyePoint Pharmaceuticals, Inc.. EyePoint Pharmaceuticals, Inc. ikhowudi yentengiso yayisezantsi izolo.

Bonisa: EyePoint Pharmaceuticals, Inc. (EYPT) Ukuze US dollar (USD)

EyePoint Pharmaceuticals, Inc. istatshi yekhredithi yemakethe

Utshintsho ngaphakathi EyePoint Pharmaceuticals, Inc. capitalization ngeveki 10.47%. Utshintsho ngaphakathi EyePoint Pharmaceuticals, Inc. capitalise ngenyanga ngu 0%. Ngonyaka uphela, EyePoint Pharmaceuticals, Inc. i-capitalization iguqulwe ngo-0%. Namhlanje, EyePoint Pharmaceuticals, Inc. capitalization ilingane 260 694 432 iidola zaseMelika.

Iveki

Inyanga

iinyanga 3

Unyaka

Iminyaka emithathu

EyePoint Pharmaceuticals, Inc. imbali yenkxaso-mali

Umhla	Ixabiso Imali-mali (intengo-mali yemarike) yixabiso lemarike yazo zonke izabelo zeenkampani ezithengiswa kwi-stock exchange. Imali yentengo yemali ilingana nexabiso lezabelo ezandisiwe ngenani lezabelo ezikhoyo.
03/05/2023	260 694 432 $
02/05/2023	222 619 328 $
01/05/2023	230 508 768 $
28/04/2023	216 153 424 $
27/04/2023	214 901 392 $
26/04/2023	270 985 024 $
25/04/2023	235 997 072 $

EyePoint Pharmaceuticals, Inc. isatifiketi somqulu

Iveki

Inyanga

iinyanga 3

Unyaka

Iminyaka emithathu

EyePoint Pharmaceuticals, Inc. idatha yembali yevolumu

Umhla	Umqulu (24h) Ixabiso lezorhwebo leEyePoint Pharmaceuticals, Inc. izabelo yintlawulo yenani lazo zonke iintengiso kunye neengxenye ze-EYPT ezithengiweyo kwaye zathengiswa ngexesha lomhla okhethiweyo.
03/05/2023	704 705 $
02/05/2023	562 395 $
01/05/2023	574 575 $
28/04/2023	301 550 $
27/04/2023	1 060 536 $
26/04/2023	3 085 755 $
25/04/2023	1 353 009 $

EyePoint Pharmaceuticals, Inc. capitalization kwiidola zaseMelika namhlanje 03/05/2023. EyePoint Pharmaceuticals, Inc. capitalisation yimali eyi- $ 222 619 328 kwi 02/05/2023. EyePoint Pharmaceuticals, Inc. capitalization e 01/05/2023 ifikelele kuthi 230 508 768 iidola zaseMelika. 28/04/2023 EyePoint Pharmaceuticals, Inc. capitalisation ilingana 216 153 424 iidola zaseMelika.

27/04/2023 EyePoint Pharmaceuticals, Inc. capitalised eyi- 214 901 392 iidola zaseMelika. EyePoint Pharmaceuticals, Inc. capitalization e 26/04/2023 ifikelele kuthi 270 985 024 iidola zaseMelika. EyePoint Pharmaceuticals, Inc. i-capitalisation yentengiso kwi 25/04/2023 ilingana ne 235 997 072 iidola zaseMelika.

Inkcitho ye-EyePoint Pharmaceuticals, Inc. namhlanje ngu-260 694 432 $. Iimali zentengiso ye-EyePoint Pharmaceuticals, Inc. ishintshile +17.1% xa kuthelekiswa nezolo. Imali yokuthengisa ye EYPT izabelo ze EyePoint Pharmaceuticals, Inc. ngosuku lokugqibela lokurhweba lilinganiselwa kuma-704 705 $. Ixabiso lokuthengiswa kwezabelo ze EyePoint Pharmaceuticals, Inc. latshintshile kwi-+25.3% xa kuthelekiswa nosuku lwangaphambili lworhwebo.